Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Quince Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +4 vs. Q2 2025
- Shares held
- 11.8M
- +4.21M (+55.6%) vs. Q2 2025
- Total value
- $19.2M
- +$6.72M (+53.7%) vs. Q2 2025
- New holders
- 8
- 13 more added
- Sold out
- 4
- 9 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 5 | $9 | 0.00% | −18−78.3% | Reduced |
| BNP Paribas Arbitrage, SA | 8 | $13 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 75 | $122 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 78 | $127 | 0.00% | +1+1.3% | Added |
| Harbour Investments, Inc. | 100 | $163 | 0.00% | 00.0% | Unchanged |
| Hurley Capital, LLC | 121 | $197 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 295 | $481 | 0.00% | 00.0% | Unchanged |
| JDM Financial Group LLC | 340 | $554 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 469 | $764 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 827 | $1.32K | 0.00% | +550+198.6% | Added |
| UBS Group AG | 1,472 | $2.40K | 0.00% | −1,374−48.3% | Reduced |
| Tower Research Capital LLC (TRC) | 1,604 | $2.62K | 0.00% | +1,604 | New |
| Bank of America Corp | 2,089 | $3.40K | 0.00% | −815−28.1% | Reduced |
| Morgan Stanley | 3,690 | $6.01K | 0.00% | −612−14.2% | Reduced |
| Advisory Services Network, LLC | 5,500 | $8.96K | 0.00% | +5,500 | New |
| Wells Fargo & Company | 6,990 | $11.4K | 0.00% | 00.0% | Unchanged |
| Nixon Peabody Trust Co | 11,126 | $18.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 15,080 | $24.6K | 0.00% | −2,306−13.3% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 15,200 | $25.0K | 0.00% | 00.0% | Unchanged |
| Anfield Capital Management, LLC | 30,227 | $49.3K | 0.01% | 00.0% | Unchanged |
| Group One Trading, L.P. | 30,830 | $50.3K | 0.00% | +30,830 | New |
| Operose Advisors LLC | 31,568 | $51.5K | 0.01% | +31,568 | New |
| Jane Street Group, LLC | 35,160 | $57.3K | 0.00% | +35,160 | New |
| Citadel Advisors LLC | 56,914 | $92.8K | 0.00% | −36,991−39.4% | Reduced |
| Northern Trust Corp | 64,706 | $105.5K | 0.00% | −12,786−16.5% | Reduced |
| Gsa Capital Partners LLP | 87,235 | $142.0K | 0.01% | +53,417+158.0% | Added |
| Simplex Trading, LLC | 88,519 | $144.0K | 0.00% | +88,519 | New |
| Scharf Investments, LLC | 91,061 | $148.4K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 95,122 | $155.0K | 0.00% | −33,495−26.0% | Reduced |
| Mariner, LLC | 122,461 | $199.6K | 0.00% | 00.0% | Unchanged |
| Shay Capital LLC | 136,955 | $223.2K | 0.04% | −13,045−8.7% | Reduced |
| Alphabet Inc. | 189,122 | $308.3K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 198,111 | $322.9K | 0.00% | +73,200+58.6% | Added |
| Marshall Wace, LLP | 210,045 | $342.4K | 0.00% | +210,045 | New |
| Union Square Park Capital Management, LLC | 224,746 | $366.3K | 0.25% | +103,889+86.0% | Added |
| HighTower Advisors, LLC | 308,500 | $502.9K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 345,461 | $563.1K | 0.00% | +9,723+2.9% | Added |
| Geode Capital Management, LLC | 437,285 | $712.9K | 0.00% | +40,303+10.2% | Added |
| Renaissance Technologies LLC | 468,598 | $763.8K | 0.00% | +88,798+23.4% | Added |
| Almitas Capital LLC | 494,778 | $806.5K | 0.18% | +494,778 | New |
| ADAR1 Capital Management, LLC | 775,034 | $1.26M | 0.13% | +632,076+442.1% | Added |
| Ieq Capital, LLC | 981,264 | $1.60M | 0.00% | +541,994+123.4% | Added |
| Millennium Management LLC | 1,386,776 | $2.26M | 0.00% | +1,276,094+1,152.9% | Added |
| Vanguard Group Inc | 1,763,387 | $2.87M | 0.00% | +309,349+21.3% | Added |
| Nantahala Capital Management, LLC | 3,073,729 | $5.01M | 0.31% | +545,427+21.6% | Added |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −169,554−100.0% | Sold out |
| Intellectus Partners, LLC | 0 | $0 | 0.00% | −53,312−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −22,660−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,004−100.0% | Sold out |